全文获取类型
收费全文 | 57884篇 |
免费 | 5069篇 |
国内免费 | 2528篇 |
出版年
2024年 | 131篇 |
2023年 | 1276篇 |
2022年 | 1549篇 |
2021年 | 2729篇 |
2020年 | 2616篇 |
2019年 | 3569篇 |
2018年 | 2665篇 |
2017年 | 1817篇 |
2016年 | 1852篇 |
2015年 | 2366篇 |
2014年 | 3634篇 |
2013年 | 4567篇 |
2012年 | 2320篇 |
2011年 | 2921篇 |
2010年 | 1995篇 |
2009年 | 2354篇 |
2008年 | 2348篇 |
2007年 | 2483篇 |
2006年 | 2232篇 |
2005年 | 2062篇 |
2004年 | 1820篇 |
2003年 | 1566篇 |
2002年 | 1511篇 |
2001年 | 1221篇 |
2000年 | 1014篇 |
1999年 | 936篇 |
1998年 | 896篇 |
1997年 | 813篇 |
1996年 | 770篇 |
1995年 | 721篇 |
1994年 | 668篇 |
1993年 | 608篇 |
1992年 | 598篇 |
1991年 | 550篇 |
1990年 | 410篇 |
1989年 | 415篇 |
1988年 | 383篇 |
1987年 | 313篇 |
1986年 | 255篇 |
1985年 | 327篇 |
1984年 | 406篇 |
1983年 | 224篇 |
1982年 | 300篇 |
1981年 | 290篇 |
1980年 | 224篇 |
1979年 | 211篇 |
1978年 | 149篇 |
1977年 | 102篇 |
1976年 | 111篇 |
1974年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
《FEBS letters》1988,240(1-2):88-94
Four subtypes of muscarinic acetylcholine receptor (mAChR) were stably expressed in neuroblastoma-glioma hybrid cells (NG108-15). By combining fluorescent indicator dye (fura-2) studies with electrophysiological measurements it is shown that stimulation of mAChR I and mAChR III readily leads to release of calcium from intracellular stores and to associated conductance changes, whereas stimulation of mAChR II and mAChR IV exerts no such effect. Dose-response curves describing the amplitude or the delay of the calcium rise induced by acetylcholine suggest that the apparent affinity of mAChR III for its agonist is higher by about one order of magnitude than that of mAChR I. Ionic substitution experiments and current fluctuation analysis indicate that calcium activates a K+-specific conductance of ‘small’ single-channel amplitude similar to the SK type [1]. Furthermore, an outward current (M current) suppressed by activation of mAChR I and mAChR III has a single-channel amplitude corresponding to a conductance of approximately 3 pS. 相似文献
92.
93.
Caroline van Haaften-Day Peter Russell Susan Carr Lesley Wright 《In vitro cellular & developmental biology. Plant》1988,24(10):965-971
Summary A cell line derived from a human ovarian carcinosarcoma was established in tissue culture and in nude mice. Two sublines,
LDF and HDF, separated by discontinuous density centrifugation were also established from the parent line JoN. The cloning
efficiency of the JoN line was 21%. Morphologic features of adenocarcinoma cells characteristic of the parent JoN cells were
retained in the sublines and clones; all lines showed the same karyotype and DNA content (pseudodiploid and pseudotetraploid).
Keratin, as demonstrated immunohistochemically, was strongly expressed in the parent line JoN and the xenograft tumor, but
not at all in the LDF sublines and only moderately in the HDF sublines. Vimentin, however, was expressed in neither the parent
line JoN nor the xenograft tumor, but was present in both sublines. Transglutaminase and plasminogen activator activity was
high in the parent line JoN. Neither, sublines nor clones showed the same high enzyme activity as the parent line. It is concluded
that this human tumor line JoN is comprised of epithelial cells, capable of multidirectional differentiation. 相似文献
94.
95.
96.
97.
98.
99.
《Molecular cell》2020,77(4):748-760.e9
- Download : Download high-res image (218KB)
- Download : Download full-size image
100.
Pancreatic cancer is a lethal disease with limited treatment options for cure. A high degree of intrinsic and acquired therapeutic resistance may result from cellular alterations in genes and proteins involved in drug transportation and metabolism, or from the influences of cancer microenvironment. Mechanistic basis for therapeutic resistance remains unclear and should profoundly impact our ability to understand pancreatic cancer pathogenesis and its effective clinical management. Recent evidences have indicated the importance of epigenetic changes in pancreatic cancer, including posttranslational modifications of proteins. We will review new knowledge on protein arginine methylation and its consequential contribution to therapeutic resistance of pancreatic cancer, underlying molecular mechanism, and clinical application of potential strategies of its reversal. 相似文献